TheEdgeResearch
Home / Stocks / ELAN

Elanco Animal Health Incorporated (ELAN)

NYSE Healthcare Drug Manufacturers - Specialty & Generic
$22.12 ▼ -8.60%
Market Cap
$11.05B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.69
52-Wk Range
16.89-27.98
CEO
Jeffrey N. Simmons
Country
US
Currency
USD

Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatologi…

Open full interactive analysis & DCF →